GERN Q4 2017 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$191,000+103.2% YoY

Gross Profit

-$2M-931.4% margin

Operating Income

-$8M-4076.4% margin

Net Income

-$7M-3889.5% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+17.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$110M

Total Liabilities

$7M

Stockholders' Equity

$104M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$191,000	$94,000	+103.2%
Gross Profit	-$2M	-$3M	+47.4%
Operating Income	-$8M	-$9M	+11.3%
Net Income	-$7M	-$8M	+12.4%